International Severe Asthma Registry_Hong Kong
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Asthma. Basic parameters: 18 years — 120 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Hong Kong
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
International Severe Asthma Registry
Overview
To ensure the care of people with severe asthma continues to improve, it is essential we have detailed information on the health and treatment of as many people with the condition as possible. The purpose of the registry is to gather this information and track the progress of patients and how well they are responding to treatment. Medical research using data from the registry will provide a better understanding of asthma and help to develop and improve the care and treatment for patients with asthma. Detailed protocol can be referred to the reference in this trial registration (International severe asthma registry \[ISAR\]: protocol for a global registry).
Detailed description
This registry is a multi-country, multicentre, observational initiative which will retrospectively and prospectively collect data regarding severe asthma patients. The key feature of the International Severe Asthma Registry will be a standardised annualised recording of:
A key set of severe asthma related data points Selected enhanced data points for optional additional data collection Standardised coding for data point variables and Standardised response options.
Asthma patients in Hong Kong will be contributing to this dataset/registry. All clinical information will be anonymised in the dataset to protect patient confidentiality.
Primary outcome measures
- Asthma exacerbations [Time frame: Every year up to 10 years]
Secondary outcome measures (1)
- Change of medications [Time frame: every year up to 10 years]
Eligibility criteria
Inclusion criteria
Patient with severe asthma with age 18 or over will be recruited.
Exclusion criteria
Patients who cannot provide written consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
Hong Kong · 1 center
- The Chinese University of Hong Kong — Hong Kong
Publications
- FitzGerald JM, Tran TN, Alacqua M, Altraja A, Backer V, Bjermer L, Bjornsdottir U, Bourdin A, Brusselle G, Bulathsinhala L, Busby J, Canonica GW, Carter V, Chaudhry I, Cho YS, Christoff G, Cosio BG, Costello RW, Eleangovan N, Gibson PG, Heaney LG, Heffler E, Hew M, Hosseini N, Iwanaga T, Jackson DJ, Jones R, Koh MS, Le T, Lehtimaki L, Ludviksdottir D, Maitland-van der Zee AH, Menzies-Gow A, Murray PMID 32819285
Identifiers
NCT: NCT07524543 · HK_ISAR_2025